RESFLOR INJECTABLE SOLUTION

Ülke: Avustralya

Dil: İngilizce

Kaynak: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktif bileşen:

FLORFENICOL; FLUNIXIN AS FLUNIXIN MEGLUMINE

Mevcut itibaren:

INTERVET AUSTRALIA PTY LIMITED

INN (International Adı):

florfenicol(300mg/mL)+flunixin as meglumine(16.5mg/mL)

Farmasötik formu:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Kompozisyon:

FLORFENICOL ANTIBIOTIC Active 300.0 mg/ml; FLUNIXIN AS FLUNIXIN MEGLUMINE BENZENE Active 16.5 mg/ml

Paketteki üniteler:

100mL; 250mL

Sınıf:

VM - Veterinary Medicine

Tarafından üretildi:

INTERVET AUSTRALIA

Terapötik grubu:

CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER

Terapötik alanı:

ANTIBIOTIC & RELATED

Terapötik endikasyonlar:

HISTOPHILUS SOMNI | MANNHEIMIA HAEMOLYTICA | PASTEURELLA MULTOCIDA | FOWL CHOLERA

Ürün özeti:

Poison schedule: 4; Withholding period: WHP: CATTLE: MILK: Do not use in female cattle which are producing or may in t he future produce milk or milk products for human consumption. MEAT: Do not u se less than 49 days before slaughter f or human consumption. TRADE ADVICE: ESI : CATTLE: DO NOT USE less than 49 days before slaughter for export. PIGS: DO NOT USE less than 12 days before slaugh ter for export. The ESI on this label w as correct at the time of label approva l. Before using this product confirm t he current ESI from the manufacturer on 1800 810 511 or the APVMA website. (ww w.apvma.gov.au/ residues//ESI.shtml); Host/pest details: CATTLE: [HISTOPHILUS SOMNI, MANNHEIMIA HAEMOLYTICA, PASTEURELLA MULTOCIDA]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE: [HISTOPHILUS SOMNI, MANNHEIMIA HAEMOLYTICA, PASTEURELLA MULTOCIDA]; For the treatment of respiratory infections caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni associated with pyrexia in non-breeding, beef cattle.DO NOT USE in female cattle which are producing or may in the future produce milk or milk products for human consumption. DO NOT USE in calves to be processed for veal. DO NOT exceed 10mL at any 1 injection site. Other RESTRAINTS, etc: See Label.

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2023-07-01

Bilgilendirme broşürü

NEW CODE
AUS 4043
01
4
REPLACES OLD CODE
N/A
COUNTRY
AU
PRODUCTNAME
Mock up Resfl or
CONCENTRATION
N/A
PRESENTATION
1x100 ml
COLORS
4
CYAN
MAGENTA
YELLOW
BLACK
N/A
N/A
N/A
N/A
N/A
RESFLOR
®
Injectable Solution is indicated for the treatment of
cattle with bovine respiratory diseases caused by _Mannheimia _
_haemolytica_, _Pasteurella multocida_ and _Histophilus somni_
associated with pyrexia.
RESFLOR
®
Injectable Solution is intended for use only in non-breeding
beef cattle; including feedlot cattle and grass-fed steers and
heifers.
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE
Restraints:
DO NOT USE in female cattle which are
producing or may in the future produce milk
or milk products for human consumption.
DO NOT USE in calves to be processed for veal.
INJECT ONLY high on the neck behind the ear.
DO NOT exceed 10mL at any one injection site.
Injection site volumes greater than 10mL may
result in injection site residues that exceed
approved limits at the Withholding Period or ESI.
DO NOT re-treat animals for 3 months after
last treatment.
Contra-indications and Special Precautions for Use:
This product is intended for use only in non-breeding beef cattle;
including feedlot cattle and grass-fed steers and heifers.
Susceptibility discs containing 30μg of fl orfenicol are available
for
sensitivity testing. Mild, transient inappetence, decreased water
consumption or diarrhoea may occur in cattle following treatment.
These symptoms should return to normal shortly after treatment.
The effect of fl orfenicol on bovine reproductive performance and
pregnancy has not been assessed. As seen with many antibiotics
high dosage and/or prolonged administration may lead to super-
infections by non-sensitive organisms such as yeasts and fungi.
Dosage and Administration:
Following removal of the fi rst dose, the contents of the vial should
be used within 28 days. Discard any unused portion.
The recommended dose rate is 2mL per 15kg bodyweight (equivalent
to 40mg/kg fl orfenicol and 2.2mg/kg fl un